Insmed (INSM) Misses Q1 EPS by 7c, Beats on Revenue
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $126.29 -0.31%
EPS Growth %: +78.3%
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +78.3%
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($1.42), $0.07 worse than the analyst estimate of ($1.35). Revenue for the quarter came in at $92.82 million versus the consensus estimate of $90.78 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
